TCG Advisors’s Zimmer Biomet ZBH Stock Holding History

TCG Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-54	Closed	-$6K	–	433
2019 Q2	$6K	Buy	54 +18	+50%	+$2.11K	0.01%	303
2019 Q1	$4K	Buy	+36	New	+$4.09K	﹤0.01%	362

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCG Advisors's ZBH Position: Q3 2019 in Review

TCG Advisors sold out of Zimmer Biomet (ZBH) in Q3 2019, closing a stake of 54 shares — an estimated $6K sold.

TCG Advisors first reported a position in ZBH in Q1 2019 and held it in 2 quarters. The position peaked at $6K in Q2 2019. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

TCG Advisors reported no remaining Zimmer Biomet position as of Q3 2019 after selling out during the quarter.
TCG Advisors sold 54 Zimmer Biomet shares in Q3 2019, an estimated $6K.
TCG Advisors first reported a position in Zimmer Biomet in Q1 2019 and held it in 2 quarters.
TCG Advisors's Zimmer Biomet position peaked at $6K in Q2 2019.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on TCG Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.